The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s cancer clinical decision tools market report forecasts the cancer clinical decision tools market size to grow to $0.65 Billion by 2027, with a CAGR (compound annual growth rate) of almost 10%.

Learn More On The Cancer Clinical Decision Tools Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Cancer Clinical Decision Tools Market Size Forecast
The global cancer clinical decision tools market is expected to grow from $0.4 billion in 2022 to $0.45 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cancer clinical decision market is expected to grow from $0.65 billion in 2027 at a CAGR of 9.9%.

Key Cancer Clinical Decision Tools Market Driver ­– Rise In The Number Of Cancer Cases Globally
For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the market’s growth.

Request for A Sample Of The Global Cancer Clinical Decision Tools Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3463&type=smp

Cancer Clinical Decision Tools Market Segment
1) By Type: Risk Assessment Tool (RAT), Qcancer
2) By End-User: Hospital, Clinics

Cancer Clinical Decision Tools Market Major Players and Strategies
Major players in the cancer clinical decision tools market are McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthcare, Elsevier B.V., Macmillan, and National Decision Support Company.

In March 2021, NeoGenomics Laboratories, Inc., a US-based company that provides clinical laboratories, pharmaceutical services, and information services and focuses on cancer genetics diagnostic testing, acquired Trapelo Health, LLC., for an amount of $65 million. Through this acquisition, NeoGenomics would be able to apply precision oncology. In order to help doctors, labs, and payers choose diagnostics and treatments, enhance clinical trial matching, expedite workflow, and enable real-time alignment with the most recent clinical data, the firm offers a first-of-its-kind, interoperable, decision-support platform. The platform makes it easier for patients to access high-quality, medically acceptable therapy alternatives. This acquisition allows NeoGenomics to utilise a single technological platform developed by Trapelo Health that enables real-time, evidence-based decision assistance, treatment selection, and reimbursement assurance for oncologists, giving patients the best chance to cure cancer. Trapelo Health, LLC., is a healthcare technology company specialising in a decision-support platform, order management, and results reporting solution for molecular testing for cancer.

The Cancer Clinical Decision Tools Global Market Report 2023 covers regional data on cancer clinical decision tools market size, cancer clinical decision tools market trends and drivers, opportunities, strategies, and cancer clinical decision tools market competitor analysis. The countries covered in the cancer clinical decision tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa

Cancer clinical decision tools refer to the tools that are developed to help medical practitioners identify suspected cancer signs and symptoms and treat patients effectively. These tools aid in clinical decision-making by assisting GPs in deciding whether to refer or seek additional diagnostic testing in patients suspected of having cancer.

View More Reports Related To The Cancer Clinical Decision Tools Market –
Cancer Vaccines Global Market Report 2023
Cancer Diagnostics Global Market Report 2023
Cancer Biologics Global Market Report 2023

Email us at [email protected]

Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Follow us on:
LinkedIn: https://bit.ly/3WzV8lZ
YouTube: https://bit.ly/3jiemhz
Global Market Model: https://bit.ly/3Was30B